Mechanistic summary: In CRC, CYP24A1 overexpression—driven by genetic, epigenetic, and inflammatory mechanisms—accelerates 1,25(OH)2D3 degradation, impairing vitamin D-mediated tumor-suppressive functions and contributing to therapeutic resistance. Here, CYP24A1 is linked to colorectal carcinoma.